Clinical Trial Update: Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating liposome-encapsulated irinotecan (PEP02) or standard irinotecan with leucovorin and 5-FU as second-line therapy for metastatic col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• Leucovorin calcium (calcium folinate)
• Liposome-encapsulated irinotecan (PEP02) (liposomal irinotecan)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED